Posted by Michael Wonder on 23 Apr 2026
EMA publishes agenda for 20-23 April 2026 CHMP meeting
20 April 2026 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue opinions for the following technologies:
- Tolebrutinib
- Onasemnogene abeparvovec
- Nerandomilast
- Palbociclib
- Plozasiran
- Ranibizumab
